1. Home
  2. RSI vs ABCL Comparison

RSI vs ABCL Comparison

Compare RSI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Street Interactive Inc.

RSI

Rush Street Interactive Inc.

HOLD

Current Price

$26.26

Market Cap

3.6B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$10.69

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSI
ABCL
Founded
2012
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
RSI
ABCL
Price
$26.26
$10.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$28.20
$8.40
AVG Volume (30 Days)
2.8M
9.0M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
933.33
10.91
EPS
0.19
N/A
Revenue
$1,134,428,000.00
$75,128,000.00
Revenue This Year
$25.44
N/A
Revenue Next Year
$14.27
$21.85
P/E Ratio
$135.79
N/A
Revenue Growth
22.76
160.56
52 Week Low
$15.51
$2.75
52 Week High
$34.53
$12.15

Technical Indicators

Market Signals
Indicator
RSI
ABCL
Relative Strength Index (RSI) 45.50 66.21
Support Level $26.00 $3.38
Resistance Level $28.77 N/A
Average True Range (ATR) 1.14 0.90
MACD 0.18 0.23
Stochastic Oscillator 46.54 77.49

Price Performance

Historical Comparison
RSI
ABCL

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: